Methylphenidate modulates motor cortical dynamics and behavior
Abstract
Methylphenidate (MPH, brand: Ritalin) is a common stimulant used both medically and non-medically. Though typically prescribed for its cognitive effects, MPH also affects movement. While it is known that MPH noncompetitively blocks the reuptake of catecholamines through inhibition of dopamine and norepinephrine transporters, a critical step in exploring how it affects behavior is to understand how MPH directly affects neural activity. This would establish an electrophysiological mechanism of action for MPH. Since we now have biologically-grounded network-level hypotheses regarding how populations of motor cortical neurons plan and execute movements, there is a unique opportunity to make testable predictions regarding how systemic MPH administration - a pharmacological perturbation - might affect neural activity in motor cortex. To that end, we administered clinically-relevant doses of MPH to Rhesus monkeys as they performed an instructed-delay reaching task. Concomitantly, we measured neural activity from dorsal premotor and primary motor cortex. Consistent with our predictions, we found dose-dependent and significant effects on reaction time, trial-by-trial variability, and movement speed. We confirmed our hypotheses that changes in reaction time and variability were accompanied by previously established population-level changes in motor cortical preparatory activity and the condition-independent signal that precedes movements. We expected changes in speed to be a result of changes in the amplitude of motor cortical dynamics and/or a translation of those dynamics in activity space. Instead, our data are consistent with a mechanism whereby the neuromodulatory effect of MPH is to increase the gain and/or the signal-to-noise of motor cortical dynamics during reaching. Continued work in this domain to better understand the brain-wide electrophysiological mechanism of action of MPH and other psychoactive drugs could facilitate more targeted treatments for a host of cognitive-motor disorders.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 3
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Unravelling the effects of methylphenidate on the dopaminergic and noradrenergic functional circuits
Ottavia Dipasquale, Daniel Martins, … Mara Cercignani·NeuropsychopharmacologyPeer-reviewed·May 30, 2020
- Methylphenidate-induced reductions in choice impulsivity are associated with alterations in cortico-striatal beta oscillations.
Jason Nan, Alyssa Terry, … Miranda Francoeur Koloski·bioRxiv·Sep 18, 2025
- Methylphenidate as a causal test of translational and basic neural coding hypotheses
Amy M. Ni, Brittany Bowes, … Marlene R. Cohen·Proceedings of the National Academy of SciencesPeer-reviewed·Apr 25, 2022
- Context of psychotropic drug delivery modulates its neurobehavioral effects: the case of methylphenidate
Roy Sar-El, Gal Raz, … Talma Hendler·bioRxiv·Nov 1, 2017
- Methylphenidate boosts choices of mental labor over leisure depending on baseline striatal dopamine
Lieke Hofmans, Danae Papadopetraki, … Roshan Cools·bioRxiv·Apr 23, 2020
- From rest to focus: Pharmacological modulation of the relationship between resting state dynamics and task-based brain activation
Kathryn Biernacki, Tianye Zhai, … Amy C. Janes·bioRxiv·Sep 30, 2025